Annette Okai, MD, FAAN

The medical director of the North Texas Institute of Neurology and Headache offered an overview of the State of the Science Summit that was held on July 21, 2022, with a variety of expert clinicians in MS care. [WATCH TIME: 3 minutes]

Drs Obeidat and Okai share clinical pearls for physicians taking care of patients with MS.

Two MS experts discuss use and efficacy of vaccinations in patients with MS, especially in patients who are on oral DMTs.

Drs Okai and Obeidat share their excitement about an emerging new drug class for the treatment of MS.

Annette Okai, MD, FAAN, discusses how she is utilizing the newer oral therapies and treatment advances in her practice.

Two MS experts discuss how the field is benefiting from availability of real-world data, given the absence of head-to-head trials.

Drs Obeidat and Okai discuss long-term data with oral DMTs that were recently presented at ACTRIMS 2022.

MS experts highlight the value of monitoring and use of risk mitigation strategies when taking care of patients with MS.

Dr Okai provides an overview of oral DMTs available to patients with RRMS.

Two MS experts discuss shared decision-making and other considerations in choosing MS treatment.

Dr Okai explains why it is important to initiate MS treatment early and to stay compliant with the treatment.

Drs Obeidat and Okai, 2 MS experts, discuss impact of relapsing-remitting multiple sclerosis (RRMS) on the quality of life of patients and caregivers.